This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/8117561.stm
The article has changed 10 times. There is an RSS feed of changes available.
| Version 6 | Version 7 |
|---|---|
| Many UK cancer deaths 'premature' | Many UK cancer deaths 'premature' |
| (about 2 hours later) | |
| Up to 15,000 people aged over 75 may be dying unnecessarily from cancer each year in the UK, according to research. | Up to 15,000 people aged over 75 may be dying unnecessarily from cancer each year in the UK, according to research. |
| The North West Cancer Intelligence Service said their lives would be prolonged if UK cancer survival rates matched the best in Europe and the US. | The North West Cancer Intelligence Service said their lives would be prolonged if UK cancer survival rates matched the best in Europe and the US. |
| Researchers said delays in diagnosing cancer in the UK and poorer treatment after diagnosis may be to blame. | Researchers said delays in diagnosing cancer in the UK and poorer treatment after diagnosis may be to blame. |
| The government's national cancer director said urgent action was needed over the study's findings. | The government's national cancer director said urgent action was needed over the study's findings. |
| The researchers, who will present their findings to the National Cancer Intelligence Network, said the number of under-75s dying in the UK was down, but little progress had been made among over-75s and the gap with other countries is growing. | The researchers, who will present their findings to the National Cancer Intelligence Network, said the number of under-75s dying in the UK was down, but little progress had been made among over-75s and the gap with other countries is growing. |
| Cancer survival rates are calculated on the basis of those who are alive five years after diagnosis. | Cancer survival rates are calculated on the basis of those who are alive five years after diagnosis. |
| POSSIBLE REASONS More invasive cancersLater diagnosis, either through delays by the patient or the NHSPoorer treatmentsPatient decision to avoid intensive therapies | POSSIBLE REASONS More invasive cancersLater diagnosis, either through delays by the patient or the NHSPoorer treatmentsPatient decision to avoid intensive therapies |
| Research into breast cancer survival rates, for example, shows that women aged over 75 have a lower chance of survival than for all ages, a difference which does not appear to be explained by their age alone. | Research into breast cancer survival rates, for example, shows that women aged over 75 have a lower chance of survival than for all ages, a difference which does not appear to be explained by their age alone. |
| Dr Tony Moran, lead researcher from the North West Cancer Intelligence Service, said elderly cancer patients did not appear to be benefitting from the improvements in treatments in the last decade. | Dr Tony Moran, lead researcher from the North West Cancer Intelligence Service, said elderly cancer patients did not appear to be benefitting from the improvements in treatments in the last decade. |
| He calculated that if the UK was performing as well as Western Europe in the age group 75-84, and as well as the US in the 85 and over age group, there would be 15,000 fewer cancer deaths among the elderly every year. | He calculated that if the UK was performing as well as Western Europe in the age group 75-84, and as well as the US in the 85 and over age group, there would be 15,000 fewer cancer deaths among the elderly every year. |
| At present, 75,000 over-75s die every year of cancer. | At present, 75,000 over-75s die every year of cancer. |
| Most worryingly, UK cancer deaths in the over-85s went up by 2% over an eight-year period, while in Western Europe they went down by 16%. | Most worryingly, UK cancer deaths in the over-85s went up by 2% over an eight-year period, while in Western Europe they went down by 16%. |
| Possible reasons include the UK being more susceptible to certain cancers related to the way we live, but many experts think it unlikely given the similarities in Western lifestyle and diet. | Possible reasons include the UK being more susceptible to certain cancers related to the way we live, but many experts think it unlikely given the similarities in Western lifestyle and diet. |
| FROM THE TODAY PROGRAMME More from Today programme | FROM THE TODAY PROGRAMME More from Today programme |
| The other possibilities include later diagnosis, and poorer treatment once that diagnosis has been reached. | The other possibilities include later diagnosis, and poorer treatment once that diagnosis has been reached. |
| "The circumstantial evidence does suggest later diagnosis," said Dr Moran. "But there are many stages where these delays may occur - the patient, the GP or the hospital." | "The circumstantial evidence does suggest later diagnosis," said Dr Moran. "But there are many stages where these delays may occur - the patient, the GP or the hospital." |
| There are surveys which indicate a lack of awareness that the chances of developing cancer increase with age, and also the notion that a "stiff upper lip" mentality may prevent some of the older generation seeking advice. | There are surveys which indicate a lack of awareness that the chances of developing cancer increase with age, and also the notion that a "stiff upper lip" mentality may prevent some of the older generation seeking advice. |
| It has also been suggested that some doctors and patients may together conclude that intensive therapy is not the best option given the toxic side-effects. | It has also been suggested that some doctors and patients may together conclude that intensive therapy is not the best option given the toxic side-effects. |
| "The point is we don't know why this is happening," said Dr Moran. "Elderly cancer survival is an area which has been grossly neglected. It is crying out for research." | "The point is we don't know why this is happening," said Dr Moran. "Elderly cancer survival is an area which has been grossly neglected. It is crying out for research." |
| Professor Mike Richards, national cancer director, said: "This is an important study and urgent action needs to be taken on the findings. | Professor Mike Richards, national cancer director, said: "This is an important study and urgent action needs to be taken on the findings. |
| "We need to ensure that cancer patients of all ages are diagnosed as early as possible and receive appropriate treatment. | "We need to ensure that cancer patients of all ages are diagnosed as early as possible and receive appropriate treatment. |
| "The findings have already been shared with the National Cancer Equality Initiative and we will be working with the NHS and other interested parties to tackle any age inequalities." | "The findings have already been shared with the National Cancer Equality Initiative and we will be working with the NHS and other interested parties to tackle any age inequalities." |
| Drug trials | Drug trials |
| Michelle Mitchell, charity director for Age Concern and Help the Aged said: "People over 65 are hugely under-represented in trials of cancer drugs, despite the fact that the majority of cancers occur in older people. | Michelle Mitchell, charity director for Age Concern and Help the Aged said: "People over 65 are hugely under-represented in trials of cancer drugs, despite the fact that the majority of cancers occur in older people. |
| This country offers some of the finest treatment and support in the world and it is scandalous that not everyone is getting this Mike HobdayMacmillan Cancer Support Fund | This country offers some of the finest treatment and support in the world and it is scandalous that not everyone is getting this Mike HobdayMacmillan Cancer Support Fund |
| "This means that clinicians don't have good information on which drugs are most effective and well-tolerated in older people with cancer. | "This means that clinicians don't have good information on which drugs are most effective and well-tolerated in older people with cancer. |
| "If the UK wants to improve its cancer mortality rates among over 75s, it should start by giving older people fairer access to clinical trials and extending the upper age limits for bowel and breast screening services." | "If the UK wants to improve its cancer mortality rates among over 75s, it should start by giving older people fairer access to clinical trials and extending the upper age limits for bowel and breast screening services." |
| Mike Hobday, Head of Policy at Macmillan Cancer Support: "It is appalling that people over 75 are not getting the care they need from the NHS. | Mike Hobday, Head of Policy at Macmillan Cancer Support: "It is appalling that people over 75 are not getting the care they need from the NHS. |
| "With an ageing population, the numbers of people getting cancer are increasing year on year. | "With an ageing population, the numbers of people getting cancer are increasing year on year. |
| "This country offers some of the finest treatment and support in the world and it is scandalous that not everyone is getting this." | "This country offers some of the finest treatment and support in the world and it is scandalous that not everyone is getting this." |
| But Professor Alan Maryon-Davis, president of the UK Faculty of Public Health, said: "As usual the people mostly missing out are from our most deprived communities. That's where the real cancer gap is." | |
| Have you had to have cancer treatment? What is your experience? How can the service be improved? Send us your comments using the form below: | Have you had to have cancer treatment? What is your experience? How can the service be improved? Send us your comments using the form below: |
| The BBC may edit your comments and not all emails will be published. Your comments may be published on any BBC media worldwide. Terms & Conditions | The BBC may edit your comments and not all emails will be published. Your comments may be published on any BBC media worldwide. Terms & Conditions |